We are live on ! Find out more
William Blair & Company

William Blair & Company Portfolio holdings

AUM $34.9B
1-Year Est. Return 18.88%
This Fund
S&P 500
This Quarter Est. Return
+4.98%
1 Year Est. Return
+18.88%
3 Year Est. Return
+73.84%
5 Year Est. Return
+90.13%
10 Year Est. Return
+512.03%
AUM
$60.5B
AUM Growth
+$4.27B
Cap. Flow
-$6.02M
Cap. Flow %
-0.01%
Top 10 Hldgs %
8.14%
Holding
2,280
New
233
Increased
803
Reduced
822
Closed
265

Top Buys

Rank Stock Value
1
ABEV icon
Ambev
ABEV
+$275M
2
BIDU icon
Baidu
BIDU
+$202M
3
AKAM icon
Akamai
AKAM
+$127M
4
IPGP icon
IPG Photonics
IPGP
+$107M
5
WP
Worldpay, Inc.
WP
+$106M

Sector Composition

Rank Sector Weight
1 Industrials 8.87%
2 Technology 6.81%
3 Consumer Discretionary 6.54%
4 Healthcare 5.75%
5 Financials 5.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CLC
826
DELISTED
Clarcor
CLC
$1.03M ﹤0.01%
15,999
+3,230
+25% +$192K
PCAR icon
827
PACCAR
PCAR
$70.2B
$1.03M ﹤0.01%
26,082
+287
+1% +$10.9K
HALO icon
828
Halozyme
HALO
$9.91B
$1.03M ﹤0.01%
68,501
WWD icon
829
Woodward
WWD
$22B
$1.03M ﹤0.01%
22,500
-450
-2% -$18.8K
TCO
830
DELISTED
Taubman Centers Inc.
TCO
$1.01M ﹤0.01%
15,810
+4,335
+38% +$289K
MUB icon
831
iShares National Muni Bond ETF
MUB
$45.4B
$1.01M ﹤0.01%
9,700
-9,200
-49% -$960K
SHW icon
832
Sherwin-Williams
SHW
$89.7B
$1M ﹤0.01%
16,395
-279
-2% -$17.1K
EWI icon
833
iShares MSCI Italy ETF
EWI
$1.07B
$1M ﹤0.01%
32,100
+4,781
+18% +$145K
FBT icon
834
First Trust NYSE Arca Biotechnology Index Fund
FBT
$2.75B
$992K ﹤0.01%
14,345
AVB icon
835
AvalonBay Communities
AVB
$27.1B
$989K ﹤0.01%
8,367
+231
+3% +$28.5K
DVA icon
836
DaVita
DVA
$12.1B
$982K ﹤0.01%
+15,500
New +$910K
BEN icon
837
Franklin Resources
BEN
$17.7B
$975K ﹤0.01%
16,885
-400
-2% -$21.6K
STLD icon
838
Steel Dynamics
STLD
$38.1B
$974K ﹤0.01%
49,875
+2,450
+5% +$44.9K
CPLA
839
DELISTED
Capella Education Company
CPLA
$966K ﹤0.01%
+14,550
New +$910K
MRCY icon
840
Mercury Systems
MRCY
$6.45B
$964K ﹤0.01%
88,055
-181,275
-67% -$1.81M
CIT
841
DELISTED
CIT Group Inc.
CIT
$964K ﹤0.01%
18,517
+3,890
+27% +$193K
CVSA
842
Covista Inc
CVSA
$4.39B
$958K ﹤0.01%
27,024
-3,904
-13% -$135K
VE
843
DELISTED
VEOLIA ENVIRONNEMENT
VE
$957K ﹤0.01%
58,550
+31,500
+116% +$528K
CEQP
844
DELISTED
Crestwood Equity Partners LP
CEQP
$942K ﹤0.01%
6,818
-137
-2% -$19.6K
CSX icon
845
CSX Corp
CSX
$94.7B
$939K ﹤0.01%
97,941
-23,397
-19% -$210K
MSCI icon
846
MSCI
MSCI
$41.6B
$932K ﹤0.01%
21,327
-600
-3% -$25.2K
ECON icon
847
Columbia Emerging Markets Consumer ETF
ECON
$338M
$930K ﹤0.01%
34,612
-4,402
-11% -$118K
PGR icon
848
Progressive
PGR
$124B
$923K ﹤0.01%
33,868
-153
-0.4% -$4.13K
HAS icon
849
Hasbro
HAS
$12.9B
$916K ﹤0.01%
16,662
-881
-5% -$45K
LVS icon
850
Las Vegas Sands
LVS
$29.7B
$913K ﹤0.01%
11,575
-875
-7% -$63K

Similar funds

William Blair & Company's Q4 2013 Portfolio in Review

As of Q4 2013, William Blair & Company held 2,280 positions worth $60.5B, up 7.6% from $56.2B the previous quarter. Its ten largest holdings account for 8.1% of the portfolio.

William Blair & Company's Q4 2013 filing shows 233 new, 803 increased, 822 reduced and 265 closed positions. Its largest new stake was Ambev: 37,612,682 shares worth $276M. The largest sale was COMPANHIA BEBIDA ADS EACH REPSTG 1 PFD SH, an estimated $237M.

By sector, the portfolio is most concentrated in Industrials at 8.9% of assets, down from 9% a quarter earlier, followed by Technology and Consumer Discretionary.

  • William Blair & Company's largest Q4 2013 buy was Ambev: 37,612,682 shares worth $276M.
  • William Blair & Company added most to Baidu in Q4 2013, an estimated $202M increase.
  • William Blair & Company's biggest Q4 2013 reduction was Perrigo, cutting an estimated $186M.
  • William Blair & Company fully exited COMPANHIA BEBIDA ADS EACH REPSTG 1 PFD SH in Q4 2013, selling an estimated $237M.
  • William Blair & Company's ten largest holdings make up 8.1% of its $60.5B portfolio in Q4 2013.
  • William Blair & Company opened 233 new positions and closed 265 in Q4 2013.
  • William Blair & Company's portfolio value rose 7.6% quarter-over-quarter to $60.5B.

Based on William Blair & Company's 13F filing for Q4 2013, filed 11 Feb 2014.